OBJECTIVES: To document the effects of the outcome of testicular sperm extraction (TESE) procedures on erectile function in patients with male factor infertility. METHODS: A total of 66 nonobstructive azoospermic patients were divided into 2 groups: group I, with sperm-positive results and group II, with sperm-negative results. The patients were evaluated with the International Index of Erectile Function-5 (IIEF-5) and Hospital Anxiety-Depression Scale. Hormones were analyzed before and 6 months after the procedure. Each group was compared with the use of the paired t test, where P <.05 was accepted as statistically significant. RESULTS: The mean patient age was 34.8 years (range 24-53). Of 66 cases, 26 (40%) experienced positive results for the TESE. The median IIEF-5 score before TESE for group I and group II was 22 (minimum: 11, maximum: 25) and 23 (minimum: 10, maximum: 25), respectively. The median IIEF-5 score after TESE for group I and group II was 23.5 (minimum: 10, maximum: 25) and 18 (minimum: 15, maximum: 25), respectively. In patients who reported new onset erectile dysfunction (ED) 6 months after surgery, the mean follicle-stimulating hormone and luteinizing hormone levels increased from 21 +/- 2 to 38 +/- 3 IU/L (P <.001), and from 11 +/- 2 to 14 +/- 2 IU/L (P >.05), respectively. The mean total testosterone level decreased from 7.83 +/- 2 to 2.8 +/- 2 ng/mL (P <.001). The Hospital Anxiety and Depression Scale revealed that patients who reported new onset ED also reported both depression and anxiety. CONCLUSIONS: Unsuccessful TESE procedures might have a negative effect on erectile function because of hormonal and psychological reasons. The andrologist should treat the ED of the patients and refer them to the psychiatrist for anxiety and depression assessment. 2010 Elsevier Inc. All rights reserved.
OBJECTIVES: To document the effects of the outcome of testicular sperm extraction (TESE) procedures on erectile function in patients with male factor infertility. METHODS: A total of 66 nonobstructive azoospermic patients were divided into 2 groups: group I, with sperm-positive results and group II, with sperm-negative results. The patients were evaluated with the International Index of Erectile Function-5 (IIEF-5) and Hospital Anxiety-Depression Scale. Hormones were analyzed before and 6 months after the procedure. Each group was compared with the use of the paired t test, where P <.05 was accepted as statistically significant. RESULTS: The mean patient age was 34.8 years (range 24-53). Of 66 cases, 26 (40%) experienced positive results for the TESE. The median IIEF-5 score before TESE for group I and group II was 22 (minimum: 11, maximum: 25) and 23 (minimum: 10, maximum: 25), respectively. The median IIEF-5 score after TESE for group I and group II was 23.5 (minimum: 10, maximum: 25) and 18 (minimum: 15, maximum: 25), respectively. In patients who reported new onset erectile dysfunction (ED) 6 months after surgery, the mean follicle-stimulating hormone and luteinizing hormone levels increased from 21 +/- 2 to 38 +/- 3 IU/L (P <.001), and from 11 +/- 2 to 14 +/- 2 IU/L (P >.05), respectively. The mean total testosterone level decreased from 7.83 +/- 2 to 2.8 +/- 2 ng/mL (P <.001). The Hospital Anxiety and Depression Scale revealed that patients who reported new onset ED also reported both depression and anxiety. CONCLUSIONS: Unsuccessful TESE procedures might have a negative effect on erectile function because of hormonal and psychological reasons. The andrologist should treat the ED of the patients and refer them to the psychiatrist for anxiety and depression assessment. 2010 Elsevier Inc. All rights reserved.
Authors: Leocácio Venícius Sousa Barroso; Ricardo Reges; João Batista Gadelha Cerqueira; Eduardo P Miranda; Rafael Jorge Alves de Alcantara; Francisco Vagnaldo F Jamacaru; Manoel Odorico de Moraes; Maria Angelina da Silva Medeiros; Lúcio Flávio Gonzaga-Silva Journal: Int Braz J Urol Date: 2018 Jan-Feb Impact factor: 1.541
Authors: Piotr Kocełak; Jerzy Chudek; Beata Naworska; Monika Bąk-Sosnowska; Barbara Kotlarz; Monika Mazurek; Paweł Madej; Violetta Skrzypulec-Plinta; Piotr Skałba; Magdalena Olszanecka-Glinianowicz Journal: Int J Endocrinol Date: 2012-07-16 Impact factor: 3.257
Authors: Jitske Eliveld; Madelon van Wely; Andreas Meißner; Sjoerd Repping; Fulco van der Veen; Ans M M van Pelt Journal: Hum Reprod Update Date: 2018-07-01 Impact factor: 15.610
Authors: Paolo Capogrosso; Christian Fuglesang S Jensen; Giulia Rastrelli; Josep Torremade; Giorgio I Russo; Amr Abdel Raheem; Anders Frey; Mikkel Fode; Mario Maggi; Yacov Reisman; Carlo Bettocchi; Giovanni Corona Journal: Sex Med Date: 2021-06-02 Impact factor: 2.491